S
State Street SPDR S&P Biotech ETF (XBI)
Sector Equity • Biotechnology
$149.80
+3.03 (+2.06%)
Market Cap: $8.30B
Last updated: Oct 16, 2026 at 1:55 PM ET
Dividends
Dividend Metrics
Forward Yield0.00%
Forward Annual Dividend$0.00
FrequencyQuarterly
Pay MonthsJun, Sep, Dec
State Street SPDR S&P Biotech ETF (XBI)
Biotechnology • USA
Net Assets (AUM)$8.30B
Expense Ratio0.3500%
Forward Yield0.00%
Portfolio Turnover43.00%
Inception DateJan 31, 2006
Sector Allocations
Healthcare96.5%
Communication Services0.0%
Consumer Discretionary0.0%
Consumer Staples0.0%
Energy0.0%
Financials0.0%
Industrials0.0%
Information Technology0.0%
Materials0.0%
Real Estate0.0%
Utilities0.0%
Technical Indicators
RSI: Neutral
RSI (14)42.70
VWAP
$149.200
Simple Moving Averages
SMA 10
$150.96
SMA 20
$153.91
SMA 50
$158.17
SMA 200
$139.97
Exponential Moving Averages
EMA 10
$150.80
EMA 20
$153.06
EMA 50
$154.75
EMA 200
$140.44
Holdings (157)
Holdings as of Oct 12, 2026
Showing 1-25 of 157
Show:
Page 1 of 7
Related GNG Research
No research available
Be the first to write about XBI
News
No news available
Company news will appear here when available
Frequently Asked Questions About XBI
Does XBI pay dividends?
State Street SPDR S&P Biotech ETF (XBI) has a dividend payment track record. See the XBI dividend history page for its current payment status, TTM yield, and recorded payments.
Get full access to GNG Research
Create a free account to access portfolio tracking, advanced tools, and more.